PUK5 Mixed Treatment Comparisons of Immunosuppressants Following Renal Transplant
نویسندگان
چکیده
منابع مشابه
tuberculosis (tb) following renal transplant
introduction: mycobacterial tuberculosis (tb) infection is a serious opportunistic infection in renal transplant patients. although tb is normally considered as an opportunistic infection of the early period, it can be diagnosed at any time. in this study four patients who suffered from tb were examined. cases report: among 200 patients who were monthly examined in sina hospital of tehran, tb w...
متن کاملDonor Transmission of Melanoma Following Renal Transplant
Donor transmission of melanoma is one of the more common and lethal of recipient malignancies, often presenting with systemic disease. Although some patients may receive durable remission of melanoma following explantation of the allograft and withdrawal of immunosuppression, donor transmission of melanoma is fatal in most patients. Here we present a case of a 44-year-old male who developed met...
متن کاملAlgorithmic parameterization of mixed treatment comparisons
Mixed Treatment Comparisons (MTCs) enable the simultaneous meta-analysis (data pooling) of networks of clinical trials comparing ≥ 2 alternative treatments. Inconsistency models are critical in MTC to assess the overall consistency between evidence sources. Only in the absence of considerable inconsistency can the results of an MTC (consistency) model be trusted. However, inconsistency model sp...
متن کاملBubbles on the skin following renal transplant.
Volume 84, Number 9 www.aafp.org/afp American Family Physician 1035 A 51-year-old man developed a mild fever and several serous vesicles on an erythematous base on his trunk (Figures 1 and 2) three months after having a renal transplant. During the following 10 days, similar lesions developed on his neck, upper arms, lower back, and inner thigh. The patient had the transplant because of end-sta...
متن کاملTargets of new immunosuppressants in renal transplantation
Although current immunosuppression is highly effective in avoiding acute rejection, it is associated with nephrotoxicity, cardiovascular morbidity, infection, and cancer. Thus, new drugs dealing with new mechanisms, as well as minimizing comorbidities, are warranted in renal transplantation. Few novel drugs are currently under investigation in Phase I, II, or III clinical trials. Belatacept is ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2011
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.08.540